Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy for the sphingolipidoses

R O Brady1

  • 1National Institutes of Health, Bethesda, MD 20892-1260, USA. robrady@codon.nih.gov

Archives of Neurology
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Sphingolipidoses are metabolic disorders where harmful lipids like glucocerebroside, G(M2) ganglioside, and sphingomyelin accumulate. These conditions, including Gaucher, Tay-Sachs, and Niemann-Pick diseases, stem from ceramide lipid storage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic intervention-based biomarkers may reduce heterogeneity and motivate targeted interventions in clinical high risk for psychosis.

Schizophrenia research·2022
Same author

Butyrylcholinesterase: an enzyme antidote for cocaine intoxication.

Addiction biology·2016
Same author

A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder.

Translational psychiatry·2012
Same author

Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice.

Neurobiology of disease·2008
Same author

Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.

Brain : a journal of neurology·2006
Same author

Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease.

Neurology·2006
Same journal

Incorrect Table Entries and Word.

Archives of neurology·2016
Same journal

IDEAL for CCSVI Research-Reply.

Archives of neurology·2013
Same journal

Atlas of Inherited Metabolic Diseases, 3rd ed.

Archives of neurology·2013
Same journal

Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

Archives of neurology·2013
Same journal

This month in archives of neurology.

Archives of neurology·2013
Same journal

About this journal.

Archives of neurology·2013
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Sphingolipidoses are a class of human metabolic storage diseases.
  • These disorders involve the harmful accumulation of glycosphingolipids and phosphosphingolipids.
  • A common structural feature of these lipids is the hydrophobic ceramide portion.

Purpose of the Study:

  • To define sphingolipidoses and provide examples of specific lipid storage disorders.
  • To illustrate the composition of key lipids involved in these diseases.
  • To highlight the accumulating lipids in Gaucher disease, Tay-Sachs disease, and Niemann-Pick disease.

Main Methods:

  • Characterization of lipid structures, focusing on ceramide and its linkages.
  • Identification of accumulating lipids in specific patient populations.

Related Experiment Videos

  • Classification of lipids based on their carbohydrate components (oligosaccharides, N-acetylneuraminic acid).

    • Main Results:

    • Glucocerebroside accumulation is characteristic of Gaucher disease.
    • G(M2) ganglioside accumulation is observed in Tay-Sachs disease.
    • Sphingomyelin accumulation is a hallmark of Niemann-Pick disease.

    Conclusions:

    • Sphingolipidoses result from the buildup of specific lipids due to metabolic defects.
    • Understanding lipid composition is crucial for diagnosing and studying these genetic disorders.
    • Examples like Gaucher, Tay-Sachs, and Niemann-Pick diseases exemplify the diverse manifestations of sphingolipidosis.